IM Cannabis Corp. Common Shares (IMCC) is a publicly traded Healthcare sector company. As of May 21, 2026, IMCC trades at $0.26 with a market cap of $1.41M and a P/E ratio of 0.00. IMCC moved +8.78% today. Year to date, IMCC is -83.26%; over the trailing twelve months it is -85.88%. Its 52-week range spans $0.22 to $7.12. Rallies surfaces IMCC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
IM Cannabis Q1 Revenue CAD 8.7M; Net Loss CAD 2.5M; G&A Down 22%: In Q1 ended March 31, 2026, IM Cannabis reported CAD 8.7 million in revenue, CAD 1.4 million gross profit, a CAD 1.7 million operating loss and CAD 2.5 million net loss. The company cut G&A expenses 22% y/y and raised liquidity through convertible notes to fund cost optimization initiatives.
| Metric | Value |
|---|---|
| Price | $0.26 |
| Market Cap | $1.41M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.12 |
| 52-Week Low | $0.22 |
| Volume | 100 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
IMCC analyst coverage data. Average price target: $0.00.